Supreme Court: State Must Be Impleaded When Relief is Sought From Public Exchequer  ||  SC: Student Fees Cannot Be Increased Mid-Course Except in Exceptional Circumstances  ||  Supreme Court: ED's Delay in Sending Arrest Order Does Not By Itself Invalidate Arrest  ||  Supreme Court: Appeal Limitation Runs From NCLAT Order Pronouncement, Not Certified Copy Receipt  ||  Gujarat High Court: Waqf Tribunal Has No Supervisory Authority Over Waqf Board  ||  Kerala High Court Orders Aadhaar Fingerprint Comparison to Trace Sreekrishnapuram Murder Culprits  ||  Delhi High Court: Unnatural Death at Police Station Alone Cannot Establish Police Negligence  ||  Orissa High Court: Teacher Scolding Student for Intoxicant Use is Not Suicide Abetment  ||  Supreme Court: Drug Users are Victims and Focus Must Be on Breaking the Supply Chain  ||  Supreme Court: Non-Signatories May Join Arbitration When the Dispute Affects Their Rights    

Competition Commission of India Levies Rs 74 Cr Fine on Himalaya Drug and Three Others - (05 Jun 2019)

MRTP/ COMPETITION LAWS

Competition Commission of India has imposed a total fine of over Rs 74 crore on Himalaya Drug Company and Intas Pharmaceuticals along with its senior officials as well as two Madhya Pradesh-based drug groupings namely Madhya Pradesh Chemists and Druggist Association and Indore Chemists Association for indulging in anti-competitive trade practices.

Tags : COMPETITION COMMISSION OF INDIA   HIMALAYA DRUG  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved